A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma

Bowles, Daniel W., Kochenderfer, Mark, Cohn, Allen · Clinical Colorectal Cancer · 2016